UBS Group Issues Pessimistic Forecast for Maravai LifeSciences (NASDAQ:MRVI) Stock Price
Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price objective trimmed by UBS Group from $8.00 to $2.50 in a report released on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. A number of other analysts have also weighed in on the stock. Bank of America cut their target price […]
Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price objective trimmed by UBS Group from $8.00 to $2.50 in a report released on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. A number of other analysts have also weighed in on the stock. Bank of America cut their target price […]
